Surgery Partners (NASDAQ:SGRY – Get Free Report) and Enhabit (NYSE:EHAB – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.
Volatility & Risk
Surgery Partners has a beta of 1.99, suggesting that its stock price is 99% more volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.
Profitability
This table compares Surgery Partners and Enhabit’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Surgery Partners | -2.28% | 1.04% | 0.41% |
| Enhabit | -0.30% | 7.24% | 3.48% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Surgery Partners | 1 | 3 | 8 | 0 | 2.58 |
| Enhabit | 1 | 6 | 2 | 0 | 2.11 |
Surgery Partners presently has a consensus price target of $22.18, indicating a potential upside of 64.43%. Enhabit has a consensus price target of $13.57, indicating a potential downside of 1.66%. Given Surgery Partners’ stronger consensus rating and higher probable upside, research analysts plainly believe Surgery Partners is more favorable than Enhabit.
Earnings & Valuation
This table compares Surgery Partners and Enhabit”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Surgery Partners | $3.31 billion | 0.53 | -$77.90 million | ($0.60) | -22.48 |
| Enhabit | $1.06 billion | 0.67 | -$4.60 million | ($0.09) | -153.33 |
Enhabit has lower revenue, but higher earnings than Surgery Partners. Enhabit is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks.
About Surgery Partners
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
About Enhabit
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
